Gracell Biotechnologies to Participate in Jefferies Healthcare Conference
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, May 24, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer and autoimmune diseases, today announced that the management team will participate in the Jefferies Healthcare Conference on June 8, 2023, in New York, NY.
The Gracell team is scheduled to present on June 8th at 8:00 am ET and will host investor meetings at the conference.
A webcast of the presentation will be available on the News and Events section of the Company's website. A replay of the webcast will be available for 90 days folowing the event. For more information, please visit ir.gracellbio.com.
Media contacts Marvin Tang [email protected] Jessica Laub [email protected] Investor contacts Gracie Tong [email protected] Stephanie Carrington [email protected]